Biological activity of 26-succinylbryostatin 1

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1312, Issue 3, 1996, Pages 197-206

  Bignami, Gary S ^a   Wagner, Fred ^b   Grothaus, Paul G ^a   Rustagi, Pradip ^b   Davis, Dana E ^a   Kraft, Andrew S ^b  

^a HAWAII BIOTECH INC   (United States)

^b Heerskink School of Medicine   (United States)

Author keywords

26 Succinylbryostatin 1; Antitumor activity; PKC; PKC translocation

Indexed keywords

26 SUCCINYLBRYOSTATIN 1; BRYOSTATIN 1; LACTONE DERIVATIVE; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

EID: 0030600229     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-4889(96)00018-3     Document Type: Article

References (41)

1. [1] Petit, G.R., Herald, C.L., Doubek, D.L., Arnold, E. and Clardy, J. (1982) Isolation and structure of bryoslatin 1. J. Am. Chem. Soc. 104: 6846-6848.
2. [2] Kraft, A.S., Smith, J.B. and Berkow, R.L. (1986) Bryostatin, an activator of calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic HL-60 cells. Proc. Nad. Acad. Sci. USA 83, 1334-1338.
3. [3] Kraft, A.S., Baker, V.V. and May, W.S. (1987) Bryostatin induces change in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic HL-60 cells. Oncogene 1, 111-118.
4. [4] Hocevar, B.A. and Fields, A.P. (1991) Selective translocation of βII-protein kinase C to the nucleus of human promeylocytic (HL-60) leukemia cells. J. Biol. Chem. 266, 28-33.
5. [5] Szallasi, Z., Smith, C.B., Pettit, G.R. and Blumberg, P.M. (1994) Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J. Biol. Chem. 269, 2118-2124.
6. [6] Pettit, G.R. (1991) in: The bryostatins. Progress in the Chemistry of Organic Natural Products, Vol. 57 (Herz, W., Kerby, G.W., Steglich, W. and Tamm, C., eds.), pp. 152-193, Springer Verlag, Vienna.
7. [7] Schuchter, L.M., Esa, A.H., May, W.S., Laulis, M.K., Pettit, G.R. and Hess, A.D. (1991) Successful treatment of murine melanoma with bryostatin 1. Cancer Res. 51, 682-687.
8. [8] Hornung, R.L., Pearson, J.W., Beckwith, M. and Longo, D.L. (1992) Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity. Cancer Res. 52, 101-107.
9. [9] Jones, R.J., Sharkis, S.J., Miller, C.B. and Rowinsky, E.K. (1990) Bryostatin 1, a unique biologic response modifier: antileukemic activity in vitro. Blood 75, 1319-1323.
10. [10] Kraft, A.S. (1993) Bryostatin 1: Will the oceans provide a cancer cure? J.N.C.I. 85, 1790-1792.
11. [11] Philip, P.A., Rea, D., Thavasu, P., Carmichael, J., Stuart, N.S.A., Rockett, H., Talbot, D.C., Ganesan, T., Pettit, G.R., Balkwill, R. and Harris, A.L. (1993) Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor a induction in vivo. J.N.C.I. 85, 1812-1818.
12. [12] Hess, A.D., Pettit, G.R. and Plessing-Menze, A. (1987) Co-induction of lymphokine synthesis by the antineoplastic bryostatin. Immunobiology 175, 420-430.
13. [13] Trenn, G., Pettit, G.R., Takayama, H., et al. (1988) Immunomodulating properties of a novel series of protein kinase C activators. The bryostatins. J. Immunol. 140, 433-439.
14. [14] Tuttle, T.M., Inge, T.H., Bethke, K.P., et al. (1992) Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1. Cancer Res. 52, 548-553.
15. [15] Prendiville, J., Crowther, D., Thatcher, N., et al. (1994) A phase I study of intravenous bryostatin 1 in patients with advanced cancer. Br. J. Cancer 68, 418-424.
16. γ. J. Biol. Chem. 269: 2961-2970.
17. [17] Quest, A.F., Bloomenthal, J., Bardes, E.S. and Bell, R.M. (1992) The regulatory domain of protein kinase C coordinates four atoms of zinc. J. Biol. Chem. 267, 10193-10197.
18. [18] Franklin, C.C., Sanchez, V., Wagner, F., Woodgett, J.R. and Kraft, A.S. (1992) Phorbol ester-induced amino-terminal phosphorylation of human JUN but not JUNB regulates transcriptional activation. Proc. Natl, Acad. Sci. USA 89, 7247-7251.
19. [19] William, F., Wagner, F., Karin, M. and Kraft, A.S. (1990) Multiple doses of diacylglycerol and calcium ionophore are necessary to activate AP-1 enhancer activity and induce markers of macrophage differentiation. J. Biol. Chem. 265, (1816)6-(1817)1.
20. [20] Ingerman-Wojenski, C.M. and Silve, M.J.A. (1984) A quick method for screening platelet dysfunctions using the whole blood lumi-aggregometer. Thromb. Haemostasis, 51, 154-156.
21. [21] Feinman, R.D., Lubowsky, J., Charo, I. and Zabinski, M.P. (1977) The lum-aggregometer a new instrument for simulataneous measurement of secretion and aggregation by platelets. J. Lab. Clin. Med. 90, 125-129.
22. [22] Schaufelberger, D.E., Chmurny, G.N. and Kolek, M.P. (1991) 1H and 13C NMR assignments of the antitumor macrolide bryostatin 1. Mag. Res. Chem. 2, 366-374.
23. [23] Kingston, D.G.I. and Zhao, Z.-Y. Water soluble derivatives of taxol. U.S. Patent #5059,699.
24. [24] Sassone-Corsi, P., Ransome, L.J., Lamph, W.W. and Verma, I.M. (1988) Direct interaction between fos and jun nuclear oncoproteins: role of the leucine zipper domain. Nature 336, 692-695.
25. [25] Chiu, R. Boyle, W.J., Meek, J., Smeal, T., Hunter, T. and Karin, M. (1988) The c-fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54, 541-552.
26. [26] Adler, V., Polotskaya, A., Wagner, F. and Kraft, A.S. Affinity-purified c-Jun amino-lerminal protein kinase requires serine/threonine phosphorylation for activity. J. Biol. Chem. 267, 17001-17005.
27. [27] Derijard, B., Hibi, M., Wu, I-H, Barrett, T., Su, B., Deng, T., Karin, M. and Davis, R.J. (1994) Jnkl: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037.
28. [28] Kyriakis, J.M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E.A., Ahmad, M.R., Avruch, J. and Woodgett, J.R. (1994) The stressactivated protein kinase subfamily of c-Jun kinases. Nature 369, 156-160.
29. [29] Rauscher, F.J.. III, Sambucetti, L.C., Curran, T., Distel, R.J. and Spiegelman, B.M. Common DNA binding site for fos protein complexes and transcription factor AP-1. Cell (1988) 52, 471-480.
30. [30] Berkow, R.L., Schlabach, L., Dodson, R., Benjamin, W.H., Pettit, G.R., Rustagi, P. and Kraft, A.S. (1993) In vivo adminsitration of the anticancer agent bryostatin 1 activates platelets and neturophils and modulates protein kinase C activity. Cancer Res, 53, 2810-2815.
31. [31] Kraft, A.S., Woodley, S., Pettit, G.R., Gao, F., Coll, J.C. and Wagner, F. (1996) Comparison of the antitumor activity of bryostatins 1,5, and 8. Cancer Chem. and Pharm., in press.
32. [32] Pettit, G.R., Lett, J.W., Herald, C.L., Kamano, Y., Boettner, F.E., Baczynskyj, L. and Nieman, R.A. (1987) Isolation and structure of bryostatins 12 and 13. J. Org. Chem. 52, 2854-2860.
33. [33] Collis, A.J. (1992) in: Drug access and prodrugs. Medicinal Chem istry. 2nd edn. (Ganellin, C.R. and Roberts, S.M. eds), pp. 61-82. Academic Press, San Diego, CA.
34. [34] Magri, N.F. and Kingston, D.G. (1988) Modified taxols, 4. Synthesis and bilogical activity of taxols modified in the side chain. J. Natl. Prod. 51, 298-306.
35. [35] Deutsch, H.M., Gliniski, J.A., Hernandez, M., Haugwitz, R.D., Narayanan, V.L., Suffness, M. and Zalkow, L.H. (1989) Synthesis of Congeners and Prodrugs. X. Water-soluble prodrugs of taxol with potent antitumor activity. J. Med. Chem. 32, 788-792.
36. [36] Wender, P.A., Cribbs, C.M., Koehler, K.F., Sharkey, N.A., Herald, C.L., Kamano, Y., Pettit, G.R. and Blumberg, P.M. (1988) Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C. Proc. Natl. Acad. Sci. USA 85, 7197-7201.
37. [37] Szallasi, Z., Smith, C.B., Pettit, G.R. and Blumberg, P.M. (1994) Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J. Biol. Chem. 269, 2118-2124.
38. [38] Grabarek, J. and Ware, J.A. (1993) Protein kinase C activation without membrane contact in platelets stimulated by bryostatin. J. Biol. Chem. 268, 5543-5549.
39. [39] Franklin, C.C., Sanchez, V., Wagner, F., Woodgett, J.R. and Kraft, A.S. (1992) Phorbol ester-induced amino-terminal phosphorylation of human Jun but not JunB regulates transcriptional activation. PNAS 89, 7247-7251.
40. [40] Stone, R.M., Sariban, E., Pettit, G.R. and Kufe, D.W. (1988) Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells. Blood 72, 208-213.
41. [41] Kraft, A.S. and Anderson, W.B. (1983) Phorbol esters increase the amount of calcium, phospholipid-dependent protein kinase associated with plasma membrane. Nature 301, 621-623.